Olema Pharmaceuticals, Inc. - Common Stock (OLMA)

Historical Holders from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
OLMA on Nasdaq
Shares outstanding
68,958,635
Price per share
$25.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
68,238,525
Total reported value
$668,035,985
% of total 13F portfolios
0%
Share change
-2,487,162
Value change
-$3,229,141
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
123
Price from insider filings
$27.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Paradigm Biocapital Advisors LP 10% $23,625,349 7,429,355 Paradigm BioCapital Advisors LP 31 Dec 2024
Bain Capital Life Sciences Opportunities IV, L.P. 10% 0% $21,763,774 -$800,807 6,843,954 -3.5% Bain Capital Life Sciences Opportunities IV, L.P. 31 Mar 2025
JANUS HENDERSON GROUP PLC 5.2% $35,105,462 3,585,849 JANUS HENDERSON GROUP PLC 30 Sep 2025
Deep Track Capital, LP 5% $10,948,209 3,442,833 Deep Track Capital, LP 31 Mar 2025
Logos Global Management LP 4.7% $10,204,222 3,208,875 Logos Global Management LP 18 Mar 2025
Point72 Asset Management, L.P. 2.3% $4,909,701 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025
As of 30 Sep 2025, Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 123 institutional shareholders filing 13F forms. They hold 68,238,525 shares. of 68,958,635 outstanding shares (99%) .

Top 25 institutional shareholders own 88% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Bain Capital Life Sciences Investors, LLC 9.9% 6,843,954 0% 4.4% $67,002,310
Paradigm Biocapital Advisors LP 9.9% 6,794,172 +0.44% 2% $66,514,944
BVF INC/IL 7.7% 5,295,893 0% 2.1% $51,846,792
BlackRock, Inc. 6.9% 4,726,394 +2.6% 0% $46,271,397
JANUS HENDERSON GROUP PLC 5.2% 3,585,849 +19% 0.02% $35,087,532
Deep Track Capital, LP 5% 3,470,172 +0.79% 0.95% $33,972,984
Logos Global Management LP 4.7% 3,208,875 0% 3.1% $31,414,886
VANGUARD GROUP INC 4.6% 3,197,320 -2.1% 0% $31,301,763
FRANKLIN RESOURCES INC 4.4% 3,011,969 0% 0.01% $29,487,177
Woodline Partners LP 3.2% 2,217,893 -37% 0.1% $21,713,172
LIGHTSPEED MANAGEMENT COMPANY, L.L.C. 2.8% 1,930,894 0% 5.9% $18,903,452
Pictet Asset Management Holding SA 2.4% 1,636,372 -13% 0.02% $16,020,082
MORGAN STANLEY 2.3% 1,555,887 +8.2% 0% $15,232,135
Vivo Capital, LLC 2.2% 1,505,862 0% 1.2% $14,742,389
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,276,005 -3.8% 0% $12,494,439
Candriam S.C.A. 1.8% 1,249,727 +47% 0.06% $12,234,827
CITADEL ADVISORS LLC 1.8% 1,236,915 -28% 0.01% $12,109,398
UBS Group AG 1.7% 1,190,654 -16% 0% $11,656,502
AMERIPRISE FINANCIAL INC 1.7% 1,147,068 -2.2% 0% $11,229,794
STATE STREET CORP 1.6% 1,093,574 +4% 0% $10,706,089
DIMENSIONAL FUND ADVISORS LP 1.5% 1,064,549 -12% 0% $10,420,648
SILVERARC CAPITAL MANAGEMENT, LLC 1.4% 933,541 1.3% $9,139,366
KINGDON CAPITAL MANAGEMENT, L.L.C. 1.2% 854,000 1.3% $8,360,660
GOLDMAN SACHS GROUP INC 1.2% 803,881 +11% 0% $7,869,995
BANK OF AMERICA CORP /DE/ 1.2% 802,304 +0.35% 0% $7,854,556

Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 71,344 $1,784,050 +$1,741,176 2,500% 4
2025 Q3 68,238,525 $668,035,985 -$3,229,141 979% 123
2025 Q2 70,511,948 $300,429,144 +$22,565,292 426% 120
2025 Q1 65,888,228 $247,927,073 -$30,654,940 376% 131
2024 Q4 71,278,859 $415,382,688 +$48,509,849 583% 154
2024 Q3 58,658,581 $700,333,058 +$12,522,075 1,194% 129
2024 Q2 57,899,300 $626,475,139 +$18,110,213 1,082% 127
2024 Q1 56,110,675 $635,162,432 +$37,694,017 1,132% 126
2023 Q4 57,467 $806,262 +$282,340 1,403% 3
2023 Q3 47,296,313 $584,109,323 +$135,064,057 1,235% 96
2023 Q2 36,381,586 $328,525,003 +$43,216,031 903% 85
2023 Q1 33,420,696 $116,011,936 +$1,787,486 347% 64
2022 Q4 33,308,067 $81,575,130 -$798,711 245% 65
2022 Q3 33,333,193 $91,990,000 -$3,940,631 275.98% 66
2022 Q2 34,176,168 $139,126,000 -$8,594,155 407.01% 68
2022 Q1 36,348,231 $155,092,471 -$17,933,682 425.99% 84
2021 Q4 38,381,637 $359,075,397 -$41,573,356 935.97% 91
2021 Q3 36,340,569 $1,001,480,449 -$19,825,144 2,755.99% 73
2021 Q2 37,382,339 $1,045,983,096 +$59,045,057 2,798% 67
2021 Q1 35,240,908 $1,158,273,244 -$1,711,119 3,318% 72
2020 Q4 34,813,365 $1,644,705,008 +$1,644,681,092 4,807.98% 55